Human Papilloma Virus, epidemiology and immunization in Victoria and the Pacific: implications for paediatricians
In this Grand Round Yasmin will discuss the evolution of our understanding of HPV and cervical cancers through the lens of a paediatric and adolescent gynaecologist. With the planned transition to later onset of cervical screening at 25 years with HPV DNA testing, she launched The Early-Onset Cervical Cancer Study Group in 2007, examining pre-vaccination virology, and cancer morphology, shedding light on predicted impact of HPV vaccination in those under 25 years.
Professor Fiona Russell and her team undertook cervical cancer epidemiology in Fiji and reviewed the cervical cancer screening program to enable the Fiji Ministry of Health to make an evidence-based decision on the introduction of HPV vaccine into the national immunisation schedule.